Abstract: A guided wave radar level gauge adapted for mounting on a nozzle of a tank, including an attachment collar with an opening configured to be aligned with the nozzle and to be secured by means of an annular clamping device, and a transmission line probe attached to an exterior end of a probe connector. The GWR level gauge further comprises an annular sealing gasket fitted in the collar opening, the annular sealing gasket having a central opening through which the central probe connector extends, and a distancing sleeve arranged around the exterior end of the probe connector and having a radially protruding collar portion, wherein processing circuitry is configured to detect an impedance change caused by tank content or condensate which has passed through the central opening of the sealing gasket and collected in an annular space immediately surrounding the radially protruding collar portion.

Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Abstract: The present invention relates to the use of myeloperoxidase inhibitors (MPO) inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Abstract: A method, system and device load balancing in a telecommunications network is provided where a selection of one or more User Equipments (UEs), to be relocated from a source cell to a target cell is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured and fed back by the target cell radio base station (RBS) to the source cell RBS, and used for updating the predicted performance value.

Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Abstract: A method, system and device load balancing in a telecommunications network is provided where a selection of one or more User Equipments (UEs), to be relocated from a source cell to a target cell is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured and fed back by the target cell radio base station (RBS) to the source cell RBS, and used for updating the predicted performance value.

Abstract: A method, system and device load balancing in a telecommunications network is provided where the selection of the one or more User Equipment (UE) 150, to be relocated from a source cell 112 to a target cell 122, is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured actually and fed back 312 by the target cell RBS 120 to the source cell RBS 110, and used for updating the predicted performance value.

Abstract: A method, system and device load balancing in a telecommunications network is provided where the selection of the one or more User Equipment (UE) 150, to be relocated from a source cell 112 to a target cell 122, is based on a prediction value of the performance in the target cell. The prediction of the performance in the target cell is performed by mapping the current load of the target cell and a current detected signal of the target cell, into a perceived performance, perceived by UEs that have been relocated previously. After relocation of the UE the perceived performance in the target cell is measured actually and fed back 312 by the target cell RBS 120 to the source cell RBS 110, and used for updating the predicted performance value.

Abstract: A sample acquiring device, an apparatus and a method for spectrophotometric measurement of high density lipoprotein (HDL) and at least one of total cholesterol (TC), triglycerides (TG) and glucose (FPG).

Abstract: A sample acquiring device, an apparatus and a method for spectrophotometric measurement of high density lipoprotein (HDL) and at least one of total cholesterol (TC), triglycerides (TG) and glucose (FPG).

Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Abstract: An antigen exposing micelle or unordered aggregate comprising at least one carrier, at least one epitope and at least one anchoring molecule, wherein said anchoring molecule comprises at least one anchoring part, intended to anchor the antigen exposing micelle to a surface.

Abstract: A method is disclosed for optically pre-aligning and referencing an antenna set-up outside an antenna measurement range. The pre-alignment is performed in an integration room close to the antenna measurement range in order to avoid unnecessary occupation of the measurement range. The method teaches a technique using generally a pair of high accuracy theodolites (T1, T2) to by means of a room mirror reference (RM) and an antenna mirror-cube transfer a difference between the co-ordinate system of an integration tower (INT) used and the measurement range antenna tower.

Abstract: A method is disclosed for optically pre-aligning and referencing an antenna set-up outside an antenna measurement range. The pre-alignment is performed in an integration room close to the antenna measurement range in order to avoid unnecessary occupation of the measurement range. The method teaches a technique using generally a pair of high accuracy theodolites (T1, T2) to by means of a room mirror reference (RM) and an antenna mirror-cube transfer a difference between the co-ordinate system of an integration tower (INT) used and the measurement range antenna tower.

Abstract: The teachings presented herein provide, among other things, improved power control stability and increased system capacity in a wireless communication network by raising signal quality targets for mobile stations engaged in scheduled uplink data transmissions and lowering those signal quality targets at the end of such transmissions. As one example, the teachings herein are applied to the Enhanced Uplink (EUL) in a Wideband CDMA (WCDMA) network. In that context, the target received signal quality (e.g., SIR) for a given mobile station's Dedicated Physical Control Channel (DPCCH) signal is raised for times when the mobile station is engaged in a scheduled data transmission via its Enhanced-Dedicated Physical Data Channel (E-DPDCH), and lowered at other times. Doing so prevents the power control loop from “chasing” the potentially dramatic changes in mobile-specific interference conditions that arise in a scheduled uplink environment.

Abstract: The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

Abstract: The present invention related to a combination of (a) a compound which is a MPO inhibitor or a pharmaceutically acceptable salt thereof and (b) a compound or a pharmaceutically acceptable salt thereof, which is used in the treatment and/or prevention of PD or Multiple Sclerosis. The invention further relates to pharmaceutical compositions comprising said combination and to methods of treating Neuroinflammatory and Neurodegenerative Disorder(s), such as PD and Multiple Sclerosis in mammals by administrating said combination. The invention further relates to a kit comprising the combination and use of said kit in treatment of Neuroinflammatory Disorder(s).